Efficacy and Safety of XG-102 in Reduction of Post-cataract Surgery Intraocular Inflammation

Clinical trial NCT02235272 · COMPLETED

Trial details

NCT number: NCT02235272
Sponsor: Xigen SA
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Inflammation Pain Cataract

Start date: 2014-09-01
Primary completion: 2015-12-01
Enrollment: 339

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.